Back to Search
Start Over
ENaC modulators and renal disease.
- Source :
-
Current molecular pharmacology [Curr Mol Pharmacol] 2013 Mar; Vol. 6 (1), pp. 35-43. - Publication Year :
- 2013
-
Abstract
- The epithelial sodium channel (ENaC) plays an essential role in transepithelial sodium reabsorption in the renal connecting tubule and collecting duct. Therefore, controlling ENaC activity is an important regulatory event in electrolyte and extracellular volume homeostasis, and thus in the control of blood pressure. Many independent signaling pathways converge on ENaC, although the most important for its physiological role is the enhancement of channel activity by the steroid hormone aldosterone. In this review, we briefly summarize current knowledge about ENaC regulation and the different chemical compounds available to directly or indirectly modify channel function. In addition, current and possible clinical uses of ENaC and aldosterone antagonists are highlighted.
- Subjects :
- Aldosterone pharmacology
Aldosterone therapeutic use
Diuretics therapeutic use
Epithelial Sodium Channel Agonists pharmacology
Epithelial Sodium Channel Agonists therapeutic use
Epithelial Sodium Channel Blockers pharmacology
Epithelial Sodium Channel Blockers therapeutic use
Epithelial Sodium Channels chemistry
Humans
Hypertension drug therapy
Kidney Diseases drug therapy
Kidney Diseases pathology
Receptors, Mineralocorticoid chemistry
Receptors, Mineralocorticoid metabolism
Signal Transduction drug effects
Sodium metabolism
Epithelial Sodium Channels metabolism
Kidney Diseases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1874-4702
- Volume :
- 6
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Current molecular pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 23547933
- Full Text :
- https://doi.org/10.2174/1874467211306010005